Event

Health Insurance Association Consortium and Celltrion to Co-Host Online Seminar for IBD Patients

Citation-Grade Primary-source linked Schema.org verified NQ 82 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published May 22, 2026 7:00 PM ・ Updated Jun 14, 2026 8:09 AM ・ 4 min read ・ Source: PR TIMES

Show contents

⚡ Key Points

The 'Consortium for Biosimilar Promotion Model Projects' by health insurance associations and Celltrion Healthcare Japan will co-host an online seminar for IBD patients across Japan on June 28, 2026.
Doctors and pharmacists will provide insights on the latest treatments and medications.

The 'Consortium for Biosimilar Promotion Model Projects' by health insurance associations and Celltrion Healthcare Japan will co-host an online seminar for IBD patients across Japan on June 28, 2026. Doctors and pharmacists will provide insights on the latest treatments and medications.

PRIMARY SOURCE Original source: https://prtimes.jp/main/html/rd/p/000000010.000130385.html Distributor: PR TIMES
Published: May 22, 2026

The 'Consortium for Biosimilar Promotion Model Projects by Health Insurance Associations' announces that, as part of efforts to promote and raise awareness about biosimilars, it will co-host an online seminar for patients with inflammatory bowel disease (IBD) across Japan in collaboration with Celltrion Healthcare Japan, Inc.

This consortium is managed by White Healthcare Co., Ltd. (Headquarters: Chuo-ku, Tokyo; Representative Director: Junichiro Ishizuka), which specializes in healthcare cost optimization consulting. This initiative has been adopted as a joint project under the Ministry of Health, Labour and Welfare's 'Subsidy for Smooth Operation of Elderly Healthcare in FY2025,' and now includes 11 participating health insurance associations with a total of approximately 1.26 million members (as of the end of FY2025).

This seminar is a new initiative where health insurance associations and a pharmaceutical company partner to provide accurate treatment information to IBD patients. Doctors and pharmacists will explain basic knowledge of medications, treatment options, and out-of-pocket costs to support patients in undergoing treatment with confidence.

Seminar Overview Date/Time: June 28, 2026 (Sun) 14:00–15:30 Format: Online Target: IBD patients across Japan Content: 'Evolving IBD Treatment! What are Molecular Targeted Drugs and Biologics?' by Dr. Takuya Araki (Associate Professor, Department of Clinical Pharmacology, Gunma University Graduate School of Medicine)

'Progress and Future of IBD Treatment: Daily life changes with the latest drugs and treatment options' by Dr. Keiji Ozeki (Director of Gastroenterology, JCHO Chukyo Hospital)

Secretariat: White Healthcare Co., Ltd.

FACT BOX

Source: PR TIMES
Category: Event

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　May 22, 2026 7:00 PM — Distributor PR TIMES
Collected　May 22, 2026 10:31 AM
AI structured & analyzed　May 22, 2026 10:35 AM
Desk-reviewed & published　May 22, 2026 7:00 PM

FAQ

What is the purpose of the online seminar?

The purpose is for health insurance cooperatives and pharmaceutical companies to collaborate and provide accurate information to IBD patients about treatment (basic knowledge of medications, treatment options, out-of-pocket costs, etc.) to support them in facing their treatment with peace of mind.

Who is the target audience for the seminar?

The target audience is IBD patients nationwide.

What is the Health Insurance Cooperative Bio-similar Promotion Model Project Consortium?

It is a framework where multiple health insurance cooperatives share knowledge and collaborate to promote awareness of biosimilars. It was established in 2024, with White Healthcare Co., Ltd. serving as the secretariat.

What is the status of this initiative?

It is recognized as a joint project under the 'Fiscal Year 2025 Subsidy for Smooth Operation of Elderly Medical Care' by the Ministry of Health, Labour and Welfare.

What kind of company is Celltrion Healthcare Japan?

It is the Japanese subsidiary of Celltrion, South Korea's largest biopharmaceutical manufacturing and exporting company. It develops and sells biosimilars and antibody biopharmaceuticals in the fields of autoimmune diseases and cancer.

Cite this article — HOW TO CITE

Washin AI News Desk“Health Insurance Association Consortium and Celltrion to Co-Host Online Seminar for IBD Patients”AI News by Washin Village（和心村）, May 22, 2026. https://aeo.idaeo.ai/ai/%E3%83%9B%E3%83%AF%E3%82%A4%E3%83%88%E3%83%98%E3%83%AB%E3%82%B9%E3%82%B1%E3%82%A2%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE/en/news/2026-05-22-health-insurance-association-consortium

AI CRAWLER ACTIVITY

as of Aug 21, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

Applebot

bot_visits_summary

2231k

last Aug 21, 2026

GPTBot

bot_visits_summary

1846k

last Aug 21, 2026

ClaudeBot

bot_visits_summary

1633k

last Aug 21, 2026

Amazonbot

bot_visits_summary

731k

last Aug 21, 2026

Bingbot

bot_visits_summary

482k

last Aug 21, 2026

Meta AI

bot_visits_summary

357k

last Aug 21, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← ホワイトヘルスケア株式会社 Back to newsroom (4)